Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
926 studies found for:    Pulmonary Disease, Chronic Obstructive: Clinical Trials
Show Display Options
Rank Status Study
1 Completed Spontaneous Breathing Trials Using Pressure-Support or T-Tube in Chronic Obstructive Pulmonary Disease Patients Weaning Mechanical Ventilation
Conditions: Weaning of Mechanical Ventilation;   Chronic Obstructive Pulmonary Disease
Interventions: Procedure: "T" Tube Spontaneous Breathing Trial;   Procedure: Pressure Support Ventilation
2 Completed The Chronic Obstructive Pulmonary Disease Fish Oil Pilot Trial
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Dietary Supplement: n-3 polyunsaturated fatty acids;   Other: Placebo
3 Completed Clinical Trial to Assess Rate of Onset of Bronchodilator Action in Severe Stable Chronic Obstructive Pulmonary Disease (COPD) Patients
Condition: Chronic Obstructive Pulmonary Disease (COPD)
Interventions: Drug: Aclidinium bromide;   Drug: Placebo Tiotropium;   Drug: Tiotropium;   Drug: Placebo LAS34273
4 Terminated
Has Results
A One Year Clinical Trial Assessing the Usefulness and Safety of Inhaled Insulin in Diabetics With COPD
Conditions: Diabetes Mellitus;   Chronic Obstructive Pulmonary Disease
Interventions: Drug: Subcutaneous Insulin;   Drug: Inhaled Insulin
5 Completed
Has Results
24-week Trial Comparing GSK573719/GW642444 With GW642444 and With Tiotropium in Chronic Obstructive Pulmonary Disease
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: GSK573719/GW642444 125/25;   Drug: GSK573719/GW642444 62.5/25;   Drug: GW642444;   Drug: tiotropium bromide
6 Completed
Has Results
24-week Trial Comparing GSK573719/GW642444 With GSK573719 and With Tiotropium in Chronic Obstructive Pulmonary Disease
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: GSK573719/GW642444 125/25;   Drug: GSK573719/GW642444 62.5/25;   Drug: GSK573719;   Drug: tiotropium bromide
7 Completed A Long-term Safety Study of Infliximab in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD).
Conditions: COPD;   Pulmonary Disease, Chronic Obstructive
Intervention: Drug: Collection of safety data for Cohort 1
8 Completed TOPIC Trial for COPD
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: Ivacaftor;   Drug: Placebo
9 Enrolling by invitation Tele-spirometry in Primary Care-Randomized Clinical Trial Cluster:Telemedicine in Chronic Obstructive Pulmonary Disease
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Other: Spirometry;   Other: telemonitoring;   Other: teleconsultation;   Other: Spirometry - 20 weeks
10 Unknown  Can Advair and Flovent Reduce Systemic Inflammation Related to Chronic Obstructive Pulmonary Disease (COPD)? A Multi-Center Randomized Controlled Trial
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: Advair;   Drug: Flovent
11 Completed Trial to Assess the Anti-inflammatory Effects of Roflumilast in Chronic Obstructive Pulmonary Disease
Conditions: COPD;   Chronic Obstructive Pulmonary Disease
Interventions: Drug: Roflumilast;   Drug: Placebo
12 Completed Efficacy of Arm Training in COPD Patients
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Procedure: comprehensive PR;   Procedure: UEET
13 Completed Bone Mineral Density Study In Patients With Chronic Obstructive Pulmonary Disease. DISKUS® Inhaler is a Trademark of the GSK Group of Companies.
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: fluticasone propionate/salmeterol powder;   Drug: salmeterol powder
14 Completed Randomized Controlled Trial of Mind-Body Breathing Therapy (in Chronic Obstructive Pulmonary Disease) To Improve Palliation of Dyspnea and Health-Related Quality of Life
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Behavioral: Relaxation Response (instruction, pocket practice card prov);   Behavioral: Mindfulness training using model developed from UMass
15 Completed A Randomized Controlled Trial to Determine Outcome and Cost Effectiveness of Case Management of Chronic Obstructive Pulmonary Disease (COPD) Patients
Condition: Chronic Obstructive Pulmonary Disease (COPD)
Intervention: Behavioral: Case Management
16 Completed
Has Results
A Trial Assessing LAS34273 in Moderate to Severe Stable Chronic Obstructive Pulmonary Disease (COPD)
Condition: Chronic Obstructive Pulmonary Disease (COPD)
Interventions: Drug: Aclidinium bromide;   Drug: Placebo
17 Completed Trial of Vitamin D Supplementation in Chronic Obstructive Pulmonary Disease
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Dietary Supplement: Cholecalciferol;   Dietary Supplement: Miglyol oil
18 Recruiting A Trial to Study the Effects of Pulmonary Rehabilitation Program on Exercise Capacity and Quality of Life in Patients With Severe Form of Chronic Obstructive Pulmonary Disease (COPD)
Conditions: Pulmonary Disease, Chronic Obstructive;   Rehabilitation
Intervention: Other: Pulmonary Rehabilitation
19 Unknown  A Randomized Comparative Effectiveness Research Trial of Three Treatments for COPD Patients
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Salbutamol (Ventolin®);   Drug: Formoterol (Oxis Turbuhaler®);   Drug: Salmeterol / fluticasone (Seretide®);   Drug: Bufei granule;   Drug: Bufeijianpi granule;   Drug: Bufeiyishen granule;   Drug: Yiqizishen granule;   Drug: conventional medicine + TCM
20 Completed Discharge Coordinator Intervention in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Other: Coordinated discharge;   Other: Control

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.